In the last trading session, 4.16 million Jade Biosciences Inc (NASDAQ:JBIO) shares changed hands as the company’s beta touched 0.86. With the company’s per share price at $9.19 changed hands at -$0.06 or -0.65% during last session, the market valuation stood at $296.25M. JBIO’s last price was a discount, traded about -46.9% off its 52-week high of $13.50. The share price had its 52-week low at $5.06, which suggests the last value was 44.94% up since then. When we look at Jade Biosciences Inc’s average trading volume, we note the 10-day average is 0.99 million shares, with the 3-month average coming to 301.35K.
Jade Biosciences Inc (NASDAQ:JBIO) trade information
Instantly JBIO was in red as seen at the end of in last trading. With action -7.08%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 73.32%, with the 5-day performance at -7.08% in the red. However, in the 30-day time frame, Jade Biosciences Inc (NASDAQ:JBIO) is 26.76% up. Looking at the short shares, we see there were 0.38 million shares sold at short interest cover period of 1.2 days.
The consensus price target for the stock as assigned by Wall Street analysts is 16.5, meaning bulls need an upside of 44.3% from its current market value. According to analyst projections, JBIO’s forecast low is 14 with 19 as the target high. To hit the forecast high, the stock’s price needs a -106.75% plunge from its current level, while the stock would need to soar -52.34% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -77.98%. The 2025 estimates are for Jade Biosciences Inc earnings to increase by 95.66%, but the outlook for the next 5-year period is at 64.67% per year.
JBIO Dividends
Jade Biosciences Inc is expected to release its next quarterly earnings report on 2025-Apr-25.
Jade Biosciences Inc (NASDAQ:JBIO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.04% of Jade Biosciences Inc shares while 31.14% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 31.16%.
